Century Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -10.3% | -88.0% | +17.5% | +309.6% | +11.2% | -25.9% | -2.1% | -36.7% | |
| – | – | – | -6.3% | +189.5% | +40.1% | -44.6% | +9.6% | -37.8% | |
| – | +10,223.1% | +105.2% | -38.2% | +107.4% | +49.3% | -43.8% | +23.5% | +5.8% | |
| – | – | – | -7.1% | +194.2% | +41.6% | -45.2% | +9.6% | -38.1% | |
| – | – | – | +638.2% | -72.5% | +212.0% | -14.7% | +128.6% | -56.1% | |
| – | -32.5% | -98.8% | -19.5% | -113.3% | – | – | – | – | |
| – | -8.8% | -99.4% | +895.9% | +134.0% | +42.8% | – | – | – | |
| – | -57.3% | – | – | – | – | – | – | +0.0% | |
| – | +18.7% | -68.2% | +16.7% | -80.7% | +346.8% | -4.3% | +9.0% | -66.2% | |
| – | -8.7% | -99.0% | +304.5% | +29.3% | +90.5% | -40.1% | +627.2% | -84.4% | |
| – | – | – | – | +589.2% | +321.8% | -78.3% | +221.9% | -31.7% | |
| – | +29.8% | -97.2% | +422.1% | -6.0% | -28.2% | -49.7% | +12.2% | +55.2% | |
| – | +76.1% | – | – | -8.0% | -58.0% | – | – | – | |
| – | -49.3% | -150.3% | – | – | -23.6% | -39.0% | -12.7% | -1.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | +0.3% | +5.0% | +2.7% | +32.6% | +10.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.